By Christine Caulfield ( October 23, 2009, 5:58 PM EDT) -- Novartis Pharmaceutical Corp. has lost the bellwether trial over its bone cancer drug Zometa, with a Montana jury awarding $3.2 million to a woman who accused the company of failing to adequately warn doctors of the drug's link to jaw deterioration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.